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Abstract
Aim Strain elastography is a novel approach to rectal
tumour evaluation. The primary aim of this study was to
correlate elastography to pT stages of rectal tumours and
to assess the ability of the method to differentiate rectal
adenomas (pT0) from early rectal cancer (pT1–2). Sec-
ondary aims were to compare elastography with endorec-
tal ultrasonography (ERUS) and to propose a combined
strain elastography and ERUS staging algorithm.
Method In all, 120 consecutive patients with a suspected
rectal tumour were examined in this staging study.
Patients receiving surgery without neoadjuvant radiother-
apy were included (n = 59). All patients were examined
with ERUS and elastography. Treatment decisions were
made by multidisciplinary team (MDT) assessment, with-
out considering the strain elastography examination.
Results Histopathology identified 21 adenomas, 13
pT1, 9 pT2, 15 pT3 and one pT4. Mean elastography
strain ratios were predictive of T stage (P = 0.01). Dif-
ferentiation of adenomas from early rectal cancer (pT1–
2) had sensitivity, specificity and accuracy of 0.82, 0.86
and 0.84 for elastography and 0.82, 0.62 and 0.72 for
ERUS. A combined staging algorithm was developed to
identify tumours eligible for local resection. Based on
MDT evaluation 32% of tumours later identified as pT0
or pT1 were treated with total mesorectal excision, even
though a local excision might have sufficed. Combined
ERUS and elastography evaluation would have signifi-
cantly reduced this number to 9% (P = 0.008).
Conclusion Elastography may improve the staging of
adenomas and early rectal cancer compared with ERUS
alone. Combined ERUS and elastography assessment is
likely to further improve the selection of patients for
local resection.
Keywords Rectal cancer, early-stage rectal neoplasms,
elastography, strain ratio, endorectal ultrasound
What does this paper add to the literature?
This paper is to our knowledge the first to demonstrate
the ability of endorectal elastography to improve staging
of pT0, pT1 and pT2 rectal tumours, proposing a com-
bined ERUS and elastography approach to early rectal
cancer staging.
Introduction
Bowel cancer screening programmes have increased
early diagnosis of rectal neoplasia [1,2]. Benign adeno-
mas and early rectal cancers confined to the submucosa
(pT1) are most appropriately offered endoluminal resec-
tion as the primary treatment [3–5] and all early cancers
(pT1/pT2) may be considered for trials of multimodal,
minimal invasive therapy [6–13]. The ability to distin-
guish adenomas (pT0) from early rectal cancers (pT1–2,
N0) has therefore become a priority, in addition to
differentiating pT1 tumours eligible for local resection
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from pT2 tumours more appropriately treated with re-
sectional surgery/total mesorectal excision.
MRI is currently unable to discriminate adenomas
from early rectal cancer [14], and even biopsies under-
stage a significant proportion of early cancers due to
intra-tumour heterogeneity [15–17]. Endorectal ultra-
sonography (ERUS) currently forms the best basis for
early rectal cancer T staging. While meta-analyses sug-
gest high precision for ERUS T staging [18,19], dis-
criminating rectal adenomas from early rectal cancer
often remains difficult [20–24].
Strain elastography [25,26] is a novel approach to rec-
tal tumour evaluation. The semi-quantification of tissue
hardness is enabled by using a quasi-static autocorrelation
real time elastography method as previously described
[21,27–29]. Strains of insonified tissue are calculated
from the frame-to-frame movement of tissue echoes
under a relatively slow compression and decompression.
Clinical application for the differentiation of benign and
malignant tumours has been validated in several organs
[30–34]. There are few studies on the evaluation of elas-
tography of rectal tumours [21,35] and to our knowl-
edge no previous study has been published assessing
elastography staging of early-stage rectal neoplasia.
The primary aim of this study was to correlate strain
ratio with pT stage and to assess the ability of endorec-
tal strain elastography to improve the staging of early-
stage rectal neoplasia compared with ERUS. As the
elastography algorithm is based on the information
provided by ERUS B-mode images, it should be
regarded as an adjunct to ERUS examination in clinical
practice. Consequently a secondary aim was to compose
a combined elastography and ERUS algorithm for the
assessment of early rectal cancer.
Method
Patients
One hundred and twenty consecutive patients referred
to Haukeland University Hospital for diagnostic evalua-
tion and staging of suspected rectal tumour were con-
sidered in this study. Results are presented from 59
patients who were not treated with preoperative radio-
therapy. Inclusion criteria were (i) patients presenting
with a sessile rectal adenoma or adenocarcinoma,
(ii) distal border ≤ 15 cm above the anal verge by rigid
rectosigmoidoscopy, (iii) subsequent surgical excision
and (iv) no use of neoadjuvant radiation therapy.
Patients who had had previous rectal surgery or pelvic
radiotherapy were also excluded. Informed consent was
mandatory. Patient characteristics are summarized in
Table 1.
ERUS and endorectal strain elastography
We used a standard ultrasonography scanner equipped
with software for elastography (Hitachi EUB-8500, soft-
ware version V16-04A; Hitachi Medical Corporation,
Kashiva, Japan). Ultrasound imaging and elastography
were performed with a rigid 360° rectal ultrasound
probe (Hitachi EUP-R54AW-19) at 10 MHz.
The patients were subjected to a same-session stan-
dardized clinical examination, ERUS and strain elastogra-
phy as described previously [21]. All examinations were
performed by a single examiner. ERUS T staging was
based on tumour growth through the rectal wall layers
according to the TNM classification system and conclu-
sions were recorded before elastography evaluation was
initiated. In one patient (pT2) the ERUS and elastogra-
phy were technically not feasible according to protocol.
A predefined strain ratio (SR) cut-off [21] was used to
distinguish adenomas from early rectal cancer.
A graded set of elastography SR cut-off levels based
on a receiver operator characteristics (ROC) analysis
was used for the combined elastography and ERUS
assessment. Based on the ROC analysis SR ≤ 0.80 iden-
tified only T0 tumours and an SR interval from 0.81 to
1.60 identified only T0–1 tumours. The latter could be
sub-stratified into intervals of SR 0.81–1.10 and SR
1.11–1.60. Finally SR ≥ 1.61 identified T2–4 tumours
Table 1 Characteristics of the 59 included patients. Mean tumour size and location above the anal verge were measured by rigid
rectoscopy.
Total pT0 pT1 pT2 pT3 pT4
Included patients 59 (100%) 21 (36%) 13 (22%) 9 (15%) 15 (25%) 1 (2%)
Age (years), mean 69 69 66 77 66 77
Treatment
TEM 23 18 5 0 0 0
Major surgery 36 3 8 9 15 1
Mean tumour location above anal verge (cm) 8 8 6 10 10 14
Mean tumour size (cm) 3 2 2 2 4 3
TEM, transanal endoscopic microsurgery.
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but also included some T0 and T1 tumours. These
intervals were combined with ERUS T staging into a
combined ERUS and elastography staging algorithm
(Figs. 1–3).
Histopathological evaluation
The examiner was not aware of any biopsy result prior
to the ERUS or elastography examination. Transanal
endoscopic microsurgery (TEM) specimens were pinned
on a plate, fixed, serially sectioned at 2–3 mm intervals
and completely embedded. Rectum resection specimens
were sliced at 3–4 mm intervals and representative sec-
tions were selected for microscopy. Tissue sections were
stained with haematoxylin and eosin.
Statistical analysis
An SR cut-off defining malignancy as SR ≥ 1.25 was
derived from pilot work in a discovery set of tumours
[21] for the initial comparison of strain elastography
and ERUS. The test validity parameters sensitivity, spec-
ificity, accuracy, negative predictive value and positive
Figure 1 A pT0 tumour situated 5–7 cm above the anal verge
involving a circumference from 7 to 10 o’clock. The split
screen image shows a B-mode image with strain ratio regions
of interest on the right-hand side and an elastogram on the
left-hand side. The tumour appears softer (more red) than the
same-depth reference tissue on the elastogram, and the strain
ratio (B/A) (SR = 0.83) is displayed in the upper left-hand
corner.
Figure 2 A pT2 tumour situated 6–9 cm above the anal verge,
involving a circumference from 11 to 3 o’clock. The split
screen image shows a B-mode image on the right-hand side,
with strain ratio regions of interest (A, tumour tissue; B, refer-
ence tissue). An elastogram is displayed on the left-hand side,
with tumour tissue appearing harder (more blue) than the
same-depth reference tissue on the elastogram. A strain ratio
(B/A) of 2.61 is displayed in the upper left-hand corner.
ERUS
Strain Ratio
Combined
Assessment
Proposed
treatment
Mucosal
resection
Full thickness
TEM surgery
Major resection
+/– neo-adjuvant
therapy
uT1–2uT0 uT3-4
≤0.80 0.81–1.10
eT0: All tumours T0,
and 
EMR would suffice
eT0-1a: Most
tumours T0, TEM
surgery with
curative intent
eT0-1b: Equally
likelyhood for
T0/1, TEM as
excision biopsy
eT2-4: Locally advanced
tumor. CT and MRI to
decide need for neo-
adjuvant treatment
>1.10 ≤0.80 0.81–1.10 1.11–1.60 >1.60
Figure 3 Flow-chart showing the combined ERUS and elastography T stage (eT) and proposed treatment, illustrating the potential
of strain ratio assessment combined with ERUS uT staging. Note that all tumours confidently defined as uT0 are eligible for local
resection regardless of strain ratio. Tumours confidently defined as uT3 or uT4 do not have any added staging benefit from com-
bined assessment and elastography can be omitted.
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predictive value were calculated for elastography SR
evaluation, ERUS evaluation, the combined assessment
algorithm and multidisciplinary team (MDT) assess-
ment.
Histopathology of the resection specimens was used
as reference standard.
One-way ANOVA was used to test for differences in
SR values between T stages. The Blyth–Still–Casella
procedure was chosen to calculate confidence intervals
(CI) of test validity parameters [36,37]. An ROC curve
analysis was performed to identify the SR cut-off for the
combined ERUS elastography T staging algorithm. The
SPSS version 21.0 (SPSS, Chicago, IL, USA), STATXACT
9.0 (Cytel Software Corporation, Cambridge, MA,
USA) and Excel (Microsoft Office Excel 2003, Micro-
soft Corporation, Redmond, WA, USA) were used for
data analysis.
Ethics
All patients received oral and written information
according to the Helsinki Declaration prior to signing
the consent form. The study was approved by the
Regional Committee for Medical and Health Research
Ethics of Western Norway.
Results
Histopathology tumour stages
Tumour stage was verified by histopathological assess-
ment as 21 adenomas (pT0), 13 pT1 tumours, nine
pT2 tumours, 15 pT3 tumours and one pT4 tumour.
One ERUS/strain elastography examination of a pT2
tumour was technically not feasible. Consequently a
total of 58 patients were included in the statistical
analyses and 42 in the sub-analysis of adenomas (pT0)
and early rectal cancers (pT1–2).
Elastography SR assessment
The elastography SR of different pT stages was signifi-
cantly different (P = 0.01, one-way ANOVA) with a
mean SR (95% CI) for individual T stages of T0, 1.03
(0.88–1.22); T1, 2.44 (1.67–3.33); T2, 6.29 (2.30–
11.55); and T3, 4.52 (2.92–11.01).
Using the predefined SR cut-off defining ≥ 1.25 as
adenocarcinomas and < 1.25 as adenomas to differenti-
ate T0 from T1–2 yielded a sensitivity of 0.82 (95% CI
0.61–0.94), a specificity of 0.86 (95% CI 0.66–0.96),
an accuracy of 0.84 (95% CI 0.71–0.93), a positive pre-
dictive value of 0.84 (95% CI 0.71–0.93) and a negative
predictive value of 0.82 (95% CI 0.61–0.94).
ERUS assessment
The isolated ERUS evaluation correctly staged 13/21
(62%) of pT0 tumours, 6/13 (46%) of pT1 tumours,
1/8 (13%) of pT2 tumours and 14/15 (93%) of pT3
tumours. Eight pT0 tumours were overstaged as either
uT1 or uT2; three pT1 were overstaged as uT2 or uT3
and four pT1 was understaged as uT0. Although 7/8
pT2 tumours were overstaged as uT3, these were inter-
preted as ‘not uT0’ for the purpose of differentiating
adenomas (pT0) from early rectal cancer (pT1–2). Con-
sequently the isolated ERUS differentiation of pT0
from pT1–2 yielded a sensitivity of 0.82 (95% CI 0.61–
0.94), a specificity of 0.62 (95% CI 0.40–0.80), an
accuracy of 0.72 (95% CI 0.58–0.85), a positive predic-
tive value of 0.69 (95% CI 0.49–0.85) and a negative
predictive value of 0.76 (95% CI 0.51–0.92).
Combined ERUS and graded elastography SR
assessment
The proposed algorithm for a combined ERUS and
elastography assessment T stage (eT) is shown in Fig. 3.
The combined eT0 assessment did not understage any
adenocarcinoma as pT0 while correctly identifying 7/
21 pT0 tumours. The eT0–1a and eT0–1b included all
remaining adenomas and 10/13 pT1 tumours. No
pT2–4 tumours were understaged with the combined
assessment. In the patient series in this study 11/34
(32.4%) of tumours subsequently identified as pT0 or
pT1 were treated with major resection based on MDT
evaluation. If the proposed combined ERUS elastogra-
phy eT staging algorithm had been applied this number
of potentially ‘unnecessary’ major resections of the rec-
tum would have been significantly reduced to 3/34
(8.8%, P = 0.008). Validity parameters are summarized
in Table 3.
Discussion
The current study is, to our knowledge, the first to
evaluate the benefit of endorectal elastography SR mea-
surements in the staging of adenomas and early rectal
cancer. Strain elastography SR measurements were
significantly different between different T stages
(P > 0.001, one-way ANOVA). However, this differ-
ence does not seem to pertain to the SRs of pT2 and
pT3 tumours, as demonstrated by their relatively wide
and overlapping confidence intervals.
Consequently the potential benefit of elastography
assessment is most likely to be related to early-stage neo-
plasia. Although ERUS is recognized as the most accu-
rate staging modality for the early tumour [18,19], the
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differentiation of stages T0–T2 is challenging and
depends on both examination technique and interpreta-
tion of the acquired images [20–24]. Our reported accu-
racy of ERUS (0.72; 95% CI 0.49–0.85) is consistent
with the literature, as the higher reported accuracies are
commonly associated with a high number of pT3
tumours and few or no pT0 tumours. When the prede-
fined cut-off value of 1.25 was used to separate T0
tumours from T1–2 tumours, the accuracy improved
compared with the assessment by ERUS (0.84; 95% CI
0.71–0.93) (Table 2). Consequently using a simple
dichotomous cut-off based on SR measurements may
improve the ability of ERUS to identify adenomas eligi-
ble for local resection.
The isolated comparison of ERUS and elastography
SR assessment is not as clinically relevant as a combined
assessment. The continuous nature of SR measurements
enables a graded approach to tumour assessment and as
elastography evaluation in clinical practice is an add-on
to the ERUS assessment a combined assessment strat-
egy is a more sensible approach than regarding them as
two distinctly separate methods. As explained in detail
in the Method section, a graded set of elastography SR
cut-off levels was deduced based on an ROC curve
analysis and combined with the preceding ERUS uT
stage. The combined ERUS and elastography T stage
(eT) is shown in Fig. 3. The algorithm was designed to
stage tumours as eT0, eT0–1a, eT0–1b or eT2–4
(Fig. 3), combining the strengths of the two methods.
If a confident distinction between uT0 and uT1 can be
made based on the ERUS assessment, a local resection
should be performed regardless of SR measurements,
but if a well-defined full-thickness submucosa is not
clearly depicted throughout the tumour the combined
eT stage should be used to decide whether a local resec-
tion would be appropriate. Also, the tendency to under-
stage T1 tumours as uT0 suggests that only tumours
with SR ≤ 0.80 should be considered for endoscopic
removal with a high likelihood of a piece-meal resection
specimen.
Our results suggest that tumours confidently defined
as uT3 or uT4 do not have any added staging benefit
from combined assessment, and elastography can conse-
quently be omitted. The suggested treatment categories
were chosen based on national and local guidelines and
would potentially differ based on the available treatment
modalities in different centres or ongoing study proto-
cols.
In this study 11/34 (32.4%) patients were treated
with resectional surgery when on the basis of pathology
(pT0 or pT1) a local excision might have been sufficient
surgical treatment. This could be considered overtreat-
ment and demonstrates the hazards of overstaging by
the combined assessment of biopsies, endoscopy, CT,
ERUS and MRI examination. Based on the proposed
combined ERUS and elastography assessment this num-
ber would have been significantly reduced to 3/34
(8.8%, P = 0.008), whilst at the same time allocating all
pT2–4 tumours for resectional surgery.
Other tumour characteristics such as size and loca-
tion of tumour, histopathological features such as
degree of differentiation, invasion in blood or lymphatic
vessels and tumour budding in addition to patient
related factors such as comorbidity, age and patient
preferences are also important as part of the clinical
decision-making process. Some pT1 tumours treated by
TEM will be offered salvage surgery in the form of a
total mesorectal excision based upon the presence of
these risk factors in the resected TEM specimen. We
recognize that all these factors should be taken into
account in future decision-making.
The identification and evaluation of mesorectal
lymph nodes are an important part of the treatment
Table 2 Elastography strain ratio and ERUS differentiation of
adenomas (pT0) and early rectal cancer (pT1–2) (95% confi-
dence interval in parentheses, Blyth–Still–Casella) using a strain
ratio of 1.25 as the cut-off value.
ERUS (n = 42) Elastography (n = 42)
Sensitivity 0.82 (0.61, 0.94) 0.82 (0.61, 0.94)
Specificity 0.62 (0.40, 0.80) 0.86 (0.66, 0.96)
Accuracy 0.72 (0.58, 0.85) 0.84 (0.71, 0.93)
PPV 0.69 (0.49, 0.85) 0.86 (0.66, 0.96)
NPV 0.76 (0.51, 0.92) 0.82 (0.61, 0.94)
PPV, positive predictive value; NPV, negative predictive values;
ERUS, endorectal ultrasonography.
Table 3 Validity parameters for combined strain elastography
and ERUS differentiation compared with MDT assessment.
Positive state was a tumour suitable for resectional surgery
(pT2–4) and negative state was a tumour suitable for local
resection (pT0–1). The reference standard was histopathologi-
cal evaluation of the surgical specimen.
Combined elastography/
ERUS assessment (n = 59)
MDT assessment
(n = 59)
Sensitivity 1.00 (0.91, 1.00) 0.88 (0.70, 0.97)
Specificity 0.88 (0.70,0.97) 0.68 (0.50, 0.81)
Accuracy 0.95 (0.86, 0.99) 0.76 (0.64, 0.86)
PPV 0.92 (0.79, 0.98) 0.67 (0.48, 0.81)
NPV 1.00 (0.87, 1.00) 0.88 (0.70, 0.97)
PPV, positive predictive value; NPV, negative predictive value;
ERUS, endorectal ultrasonography; MDT, multidisciplinary
team.
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decision, but elastography evaluation of lymph nodes
was beyond the scope of this study.
Although a rigorous protocol for choosing tumour
tissue and reference tissue on the B-mode pictures
before elastography was applied to minimize bias, all
elastography examinations was performed by one exam-
iner immediately following the ERUS examination.
Consequently an observer bias is possible. A sampling
algorithm for SR evaluation was designed to avoid this,
ensuring that only a grey-scale B-mode image was visi-
ble when regions of interest were chosen. Due to tech-
nical limitations regarding the format of saved
elastography video loops and images, a blinded SR
re-examination was not possible, making a reliability eval-
uation of elastography SR measurements unattainable.
In this study we have used a strain imaging method
(extended combined autocorrelation method). Other
elastography methods are available in combination with
ultrasound imaging, based on vibration or shear-wave
speed measurements. These algorithms have not been
available, however, with probes designed for 360° imag-
ing of rectal structures. It is important to note that
other elastography algorithms or even updated software
versions of strain elastography may produce different
cut-off values. Definite cut-off values should be vali-
dated before being applied in clinical practice, but our
findings suggest that the differences in strain patterns
are due to morphological differences between adeno-
mas, early rectal cancers and locally advanced cancers
and as such the principle of eT staging is most probably
applicable to other elastography algorithms.
In conclusion, the evaluation of rectal neoplasms by
strain elastography may improve the preoperative stag-
ing of adenomas and early rectal cancer. A combined
ERUS and elastography T staging seems able to
improve the selection of patients for local resection.
Future studies should be aimed at assessing the com-
bined ERUS and elastography assessment as an integral
part of the pretreatment algorithm to evaluate the
actual impact on treatment decisions.
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